特应性皮炎管理指南：第 1 节。特应性皮炎的诊断和评估。
Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis.
机构信息
Division of Pediatric and Adolescent Dermatology, Rady Children's Hospital San Diego, San Diego, California.
Department of Dermatology, Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois.
出版信息
J Am Acad Dermatol. 2014 Feb;70(2):338-51. doi: 10.1016/j.jaad.2013.10.010. Epub 2013 Nov 27.
Abstract
Atopic dermatitis (AD) is a chronic, pruritic, inflammatory dermatosis that affects up to 25% of children and 2% to 3% of adults. This guideline addresses important clinical questions that arise in the management and care of AD, providing updated and expanded recommendations based on the available evidence. In this first of 4 sections, methods for the diagnosis and monitoring of disease, outcomes measures for assessment, and common clinical associations that affect patients with AD are discussed. Known risk factors for the development of disease are also reviewed.
摘要
特应性皮炎（AD）是一种慢性、瘙痒性、炎症性皮肤病，影响多达 25%的儿童和 2%至 3%的成年人。本指南针对 AD 管理和护理中出现的重要临床问题，根据现有证据提供更新和扩展的建议。在这 4 个部分中的第 1 部分中，讨论了疾病的诊断和监测方法、评估的结果测量以及影响 AD 患者的常见临床关联。还回顾了疾病发展的已知危险因素。
相似文献
1
Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis.
J Am Acad Dermatol. 2014 Feb;70(2):338-51. doi: 10.1016/j.jaad.2013.10.010. Epub 2013 Nov 27.
2
Assessment of clinical signs of atopic dermatitis: a systematic review and recommendation.
J Allergy Clin Immunol. 2013 Dec;132(6):1337-47. doi: 10.1016/j.jaci.2013.07.008. Epub 2013 Sep 12.
3
Comparison of Patient-Oriented Eczema Measure and Patient-Oriented Scoring Atopic Dermatitis vs Eczema Area and Severity Index and other measures of atopic dermatitis: A validation study.
Ann Allergy Asthma Immunol. 2020 Jul;125(1):78-83. doi: 10.1016/j.anai.2020.03.006. Epub 2020 Mar 18.
4
Validation of five patient-reported outcomes for atopic dermatitis severity in adults.
Br J Dermatol. 2020 Jan;182(1):104-111. doi: 10.1111/bjd.18002. Epub 2019 Jul 24.
5
Analysis of correlations between patient-oriented SCORAD (PO-SCORAD) and other assessment scores of atopic dermatitis severity and quality of life.
Dermatology. 2014;229(3):248-55. doi: 10.1159/000365075. Epub 2014 Aug 29.
6
Prevalence and burden of atopic dermatitis involving the head, neck, face, and hand: A cross sectional study from the TARGET-DERM AD cohort.
J Am Acad Dermatol. 2023 Sep;89(3):519-528. doi: 10.1016/j.jaad.2023.04.052. Epub 2023 May 5.
7
Approach to the Assessment and Management of Adult Patients With Atopic Dermatitis: A Consensus Document. Section II: Tools for Assessing the Severity of Atopic Dermatitis.
J Cutan Med Surg. 2018 Nov/Dec;22(1_suppl):10S-16S. doi: 10.1177/1203475418803628.
8
Longitudinal course and phenotypes of health-related quality of life in adults with atopic dermatitis.
Clin Exp Dermatol. 2022 Feb;47(2):359-372. doi: 10.1111/ced.14948. Epub 2021 Nov 10.
9
Severity strata for Eczema Area and Severity Index (EASI), modified EASI, Scoring Atopic Dermatitis (SCORAD), objective SCORAD, Atopic Dermatitis Severity Index and body surface area in adolescents and adults with atopic dermatitis.
Br J Dermatol. 2017 Nov;177(5):1316-1321. doi: 10.1111/bjd.15641. Epub 2017 Oct 1.
10
Attentiveness and mental health in adolescents with moderate-to-severe atopic dermatitis without ADHD.
Arch Dermatol Res. 2024 Jul 30;316(8):497. doi: 10.1007/s00403-024-03210-x.
引用本文的文献
1
Pediatric Atopic Dermatitis Exhibits Distinctive Patterns in JAK/STAT Pathway Activation and CD6-ALCAM Signaling.
Immune Netw. 2025 Jun 20;25(4):e26. doi: 10.4110/in.2025.25.e26. eCollection 2025 Aug.
2
Rocatinlimab: A Novel T-Cell Rebalancing Therapy Targeting the OX40 Receptor in Atopic Dermatitis.
Dermatol Ther (Heidelb). 2025 Sep 6. doi: 10.1007/s13555-025-01492-1.
3
Pre-chewing for weaning: A traditional method for allergy prevention? Rationale, study design, and methods of the open-label trial-Solids-by-Kiss.
Pediatr Allergy Immunol. 2025 Aug;36(8):e70147. doi: 10.1111/pai.70147.
4
Shifting Epidemiology of Atopic Dermatitis in Korean Children: Clinical and Public Health Perspectives.
Allergy Asthma Immunol Res. 2025 Jul;17(4):409-413. doi: 10.4168/aair.2025.17.4.409.
5
Unilateral Osteonecrosis of the Femoral Head in a Patient with Atopic Dermatitis Due to Uncontrolled Topical Steroid Treatment, a Case Report.
Reports (MDPI). 2025 May 11;8(2):65. doi: 10.3390/reports8020065.
6
Efficacy and Safety of Lebrikizumab in Adult and Adolescent Patients with Skin of Color and Moderate-to-Severe Atopic Dermatitis: Results from the Phase IIIb, Open-Label ADmirable Study.
Am J Clin Dermatol. 2025 Jul 15. doi: 10.1007/s40257-025-00970-8.
7
European, multicentre, prospective observational phase IV clinical study to assess the impact of lebrikizumab on health-related well-being and control of skin manifestations in patients with moderate-to-severe atopic dermatitis (ADTrust): study protocol.
BMJ Open. 2025 Jul 11;15(7):e102155. doi: 10.1136/bmjopen-2025-102155.
8
Budget Impact Analysis of Lebrikizumab for Treating Severe Atopic Dermatitis.
Dermatol Ther (Heidelb). 2025 Jul 9. doi: 10.1007/s13555-025-01475-2.
9
Efficacy and safety of dupilumab in the treatment of moderate-to-severe atopic dermatitis: a real-life study.
Drugs Context. 2025 Jun 19;14. doi: 10.7573/dic.2025-3-5. eCollection 2025.
10
Effects of dupilumab on quality of life in patients with atopic dermatitis: a systematic review and meta-analysis of randomized controlled trials.
Front Pharmacol. 2025 Jun 10;16:1587977. doi: 10.3389/fphar.2025.1587977. eCollection 2025.
本文引用的文献
1
New concept of the pathogenesis of atopic dermatitis: interplay among the barrier, allergy, and pruritus as a trinity.
J Dermatol Sci. 2013 Apr;70(1):3-11. doi: 10.1016/j.jdermsci.2013.02.001. Epub 2013 Feb 15.
2
Atopic dermatitis: a practice parameter update 2012.
J Allergy Clin Immunol. 2013 Feb;131(2):295-9.e1-27. doi: 10.1016/j.jaci.2012.12.672.
3
Mental health comorbidity in patients with atopic dermatitis.
J Allergy Clin Immunol. 2013 Feb;131(2):428-33. doi: 10.1016/j.jaci.2012.10.041. Epub 2012 Dec 13.
4
A comparison of criteria for diagnosis of atopic dermatitis in children.
World J Pediatr. 2012 Nov;8(4):355-8. doi: 10.1007/s12519-012-0381-1. Epub 2012 Nov 15.
5
Understanding and managing atopic dermatitis in adult patients.
Semin Cutan Med Surg. 2012 Sep;31(3 Suppl):S18-22. doi: 10.1016/j.sder.2012.07.006.
6
Maternal dietary antigen avoidance during pregnancy or lactation, or both, for preventing or treating atopic disease in the child.
Cochrane Database Syst Rev. 2012 Sep 12;2012(9):CD000133. doi: 10.1002/14651858.CD000133.pub3.
7
Towards global consensus on outcome measures for atopic eczema research: results of the HOME II meeting.
Allergy. 2012 Sep;67(9):1111-7. doi: 10.1111/j.1398-9995.2012.02874.x. Epub 2012 Jul 30.
8
Guidelines for treatment of atopic eczema (atopic dermatitis) Part II.
J Eur Acad Dermatol Venereol. 2012 Sep;26(9):1176-93. doi: 10.1111/j.1468-3083.2012.04636.x. Epub 2012 Jul 19.
9
Guidelines for treatment of atopic eczema (atopic dermatitis) part I.
J Eur Acad Dermatol Venereol. 2012 Aug;26(8):1045-60. doi: 10.1111/j.1468-3083.2012.04635.x.
10
Probiotics supplementation during pregnancy or infancy for the prevention of atopic dermatitis: a meta-analysis.
Epidemiology. 2012 May;23(3):402-14. doi: 10.1097/EDE.0b013e31824d5da2.
Zotero 插件